Status:
RECRUITING
Study of Contrast - Induced Nephropathy After Intravenous Contrast Procedures at Sohag University Hospitals
Lead Sponsor:
Sohag University
Conditions:
Contract Induced Nephropathy
Eligibility:
MALE
18+ years
Brief Summary
Contrast-induced nephropathy (CIN) is a serious complication of angiographic procedures and results from administration of iodinated contrast media (CM). CIN is the third most common cause of hospita...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 1- Inpatients and outpatients aged 18years and above who underwent single intravenous Contrast procedures.
- Exclusion criteria:
- Patients below 18 years, failure to obtain consent.
- Patients with ESRD/ on maintenance hemodialysis.
- New-York Heart Association class IV Congestive Cardiac Failure (CCF) or patients with cardiogenic shock .
- History of hypersensitivity to contrast in the past or exposure to contrast in the last 24-48 hours, 5-nursing/pregnant subjects.
- Patients with malignancy or other organ failure like decompensated liver cirrhosis
Exclusion
Key Trial Info
Start Date :
March 12 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 12 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06965764
Start Date
March 12 2025
End Date
September 12 2025
Last Update
May 14 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university hospitals
Sohag, Egypt
2
Sohag university hospitals
Sohag, Egypt